MBX Biosciences, Inc. Common Stock (MBX NASDAQ) stock market data APIs
$31.8795
-1.52(-4.8%)
as of May 6, 2026
Try our APIs with
free plan!
MBX Biosciences, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
Prev. Close
31.8795
Open
30.3573
High
32.3052
Low
28.7815
52 wk Range
9.43-44.89
Market Cap
1 528 M
Shares Outstanding
47 570 K
EPS
-0.49
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MBX Biosciences, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MBX Biosciences, Inc. Common Stock data using free add-ons & libraries
Get MBX Biosciences, Inc. Common Stock Fundamental Data
MBX Biosciences, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -97 807 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get MBX Biosciences, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-23
- EPS/Forecast: -0.5967
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MBX Biosciences, Inc. Common Stock News
New
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award
MBX Biosciences, Inc. CARMEL, Ind. and BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, de...
3 Overlooked Stocks Set to Soar in 2026
Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize growth for investors. Axsome Therapeutics(NASDAQ: AXSM) is a mid-cap with o...
3 Overlooked Stocks Set to Soar in 2026
Key Points Axsome Therapeutics and NovoCure Limited recently received FDA approvals for their therapies. MBX Biosciences is expecting late-stage clinical trial readouts this year. None of these three...
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase
What happened According to a filing with the Securities and Exchange Commission dated April 21, 2026, Aaron Wealth Advisors LLC bought 1,098,176 shares of MBX Biosciences(NASDAQ:MBX) during the first...
Get MBX Biosciences, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
